Mandate

VINGE ADVISES THE AIRPORT OPERATOR ABERTIS IN CONNECTION WITH THE SALE OF STOCKHOLM SKAVSTA AIRPORT

July 25, 2013

Vinge has advised the Spanish airport operator, Abertis Infraestructuras S.A. in connection with the sale of the British subsidiary, TBI, and its subsidiary, Stockholm Skavsta Flygplata AB. Stockholm Skavsta Flygplats is being sold together with airports in Belfast and Orlanda Sanford (Florida) airport terminal as well as TBI’s other management operations at airports in the United States to the North American airport operator, ADC & HAS Airports Worldwide. Stockholm Skavsta airport is Sweden’s third largest airport with approximately 2.5 million passengers per year. The airport has been owned by Abertis since 2005. The municipality of Nyköping will continue to hold 9.9% of the shares in Stockholm Skavsta Flygplats AB. The transaction is conditional upon approval by the relevant competition authorities and other public authorities.

Vinge’s team consisted of partner Michael Wigge together with, among others, associates Paul Dali (M&A), Johan Cederblad (real estate and environmental) and Åsa Gotthardsson (employment and pensions).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025